Skip to main content

Table 2 Drug resistance patterns of Mycobacterium tuberculosis isolates

From: Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya

Category

New cases

Retreatment cases

All cases

N (%)

95 % CI

N (%)

95 % CI

N (%)

95 % CI

Total patients

N = 160

 

N = 24

 

N = 184

 

Any Resistance

56 (35 %)

27.61–42.39

5 (20.8)

4.56–37.04

61 (33.1)

26.3–39.3

Any Resistance to:

 STR

10 (6.25)

2.5–10.0

3 (12.5)

0.73–25.73

13 (7.1)

3.39–10.81

 INH

40 (25)

18.29–31.71

4 (20)

4.0–36.0

44 (23.9)

17.74–30.06

 RIF

10 (6.25)

2.5–10.0

2 (8.3)

2.74–19.34

12 (6.5)

2.94–10.06

 EMB

21 (13)

7.87–18.33

4 (16.7)

1.78–31.62

25 (13.6)

8.65–18.55

Mono Resistance to

 STR

4 (2.5)

0.08–4. 92

0 (0)

-

4 (2.2)

0.08–4.32

 INH

25 (15.6)

9.98–21.22

0 (0)

-

25 (13.6)

8.65–18.55

 RIF

1 (0.63)

0.6–1.86

0 (0)

-

1 (0.5)

0.52–1.52

 EMB

10 (6.25)

2.5–10.0

1 (4.16)

3.83–12.15

11 (6.0)

2.57–9.43

INH + RIF Resistant (MDR)

 INH + RIF only

4 (2.5)

0.08–4.92

0 (0)

-

4 (2.2)

0.08–4.32

 INH + RIF + EMB

1 (0.63)

0.6–1.86

0 (0)

-

1 (0.5)

0.52–1.52

 INH + RIF + STR

0 (0)

 

0 (0)

-

0 (0)

-

 INH + RIF + EMB + STR

2 (1.25)

0.47–2.97

2 (8.3)

2.74–19.34

4 (2.2)

0.08–4.32

 Total MDR

7 (4.4)

1.22–7.58

2 (8.3)

2.74–19.34

9 (4.9)

1.78–8.02

INH + other Resistance

 INH + STR

3 (1.9)

0.22–4.02

1 (4.16)

3.83–12.15

4 (2.2)

0.08–4.32

 INH + EMB

5 (3.1)

0.41–5.79

1 (4.16)

3.83–12.15

6 (3.3)

0.72–5.88

 INH + STR + EMB

1 (0.63)

0.6–1.86

0 (0)

-

1 (0.5)

0.52–1.52

RIF + other Resistance

 RIF + EMB

1 (0.63)

0.6–1.86

0 (0)

-

1 (0.5)

0.52–1.52

 RIF + STR + EMB

1 (0.63)

0.6–1.86

0 (0)

-

1 (0.5)

0.52–1.52